What is the market cap of Lotus Eye Hosp & Inst L?

As of 18/05/2026, the market cap of Lotus Eye Hosp & Inst L stands at ₹216.30 Cr.

What is the PE and PB ratio of Lotus Eye Hosp & Inst L?

The PE and PB ratios of Lotus Eye Hosp & Inst L is 345.16 ratio and 29.14 ratio as of 18/05/2026.

What is the 52 week high and low of Lotus Eye Hosp & Inst L?

The 52 week high and low of Lotus Eye Hosp & Inst L is ₹147 and ₹67.72 as of 18/05/2026.

How can I buy Lotus Eye Hosp & Inst L share?

You can easily buy Lotus Eye Hosp & Inst L shares on the Bajaj Broking platform by opening a Demat account and verifying your KYC documents online. There are no account opening charges for a Demat account with Bajaj Broking.

What determines a company’s share price?

A company’s share price is determined by supply and demand dynamics in the stock market. Factors influencing it include the company’s financial performance, earnings growth, revenue, and profitability, as well as broader economic conditions, market sentiment, and investor perception. Other determinants include sector trends, government policies, interest rates, and global events. Positive news or growth prospects can drive demand and raise the share price, while negative developments can push it lower. Analysts’ recommendations, institutional buying or selling, and technical factors such as trading volume also influence price movements. Ultimately, the share price reflects the market’s collective view of a company’s current and future value.

What is the “last sale,” “bid,” and “ask” price of Lotus Eye Hosp & Inst L?

The “last sale” is the most recent price at which a stock, like Lotus Eye Hosp & Inst L , was traded. The “bid” price represents the highest price buyers are willing to pay, while the “ask” price is the lowest price sellers are ready to accept. The difference between the bid and ask is known as the spread. Monitoring these prices helps investors understand market sentiment and liquidity. For example, a narrow spread indicates high liquidity and active trading, while a wide spread may suggest lower activity or higher volatility. These metrics are crucial for executing timely buy or sell orders in the stock market.

How to read share price charts for Lotus Eye Hosp & Inst L?

Share price charts display the historical price movement of Lotus Eye Hosp & Inst L , helping investors analyse trends, patterns, and potential entry or exit points. Charts typically show candlestick patterns, line graphs, or bar charts, representing open, high, low, and close prices. Key indicators include moving averages, support and resistance levels, and trading volume. Candlestick patterns can reveal bullish or bearish trends, while volume confirms the strength of price movements. Investors can use charts for technical analysis to assess momentum, predict short-term fluctuations, or complement fundamental analysis for long-term decisions. Understanding trends over daily, weekly, or monthly periods helps in making informed trading and investment choices.

What is volatility, and how does it affect share price movement for Lotus Eye Hosp & Inst L?

Volatility measures the degree of price fluctuations of a stock over time. High volatility indicates that Lotus Eye Hosp & Inst L share price can experience large swings in short periods, while low volatility suggests stable prices. Factors causing volatility include market sentiment, earnings announcements, global events, economic indicators, and industry news. High volatility can create opportunities for traders to profit from rapid price changes but also increases risk for long-term investors. Understanding volatility helps investors manage risk, set stop-loss limits, and determine the appropriate investment horizon based on their risk tolerance.

LOTUS EYE HOSP & INST L

LOTUSEYE

Small Cap | Healthcare

₹104.88

-1.68 (-1.57%)

‌

Stock price as on 18 May 2026 at 14:19 PM

Lotus eye hosp & inst l share price update

As of the latest trading session, Lotus Eye Hosp & Inst L share price is currently at ₹104.88, which is down by ₹-1.68 from its previous closing. Toda...

Lotus Eye Hosp & Inst L stock performance

Today’s low

₹101.02

Today’s high

₹106.56

₹104.88

52 week low

₹67.72

52 week high

₹147

₹104.88

Open

₹106.56

Previous close

₹106.56

Share volume

1,723

Total traded value (Lakh)

₹1.79

Upper circuit

₹117.21

Lower circuit

₹95.91

Lotus Eye Hosp & Inst L fundamentals

Market cap (Cr)

₹216.30

P/E ratio (TTM)

345.16

Book value per share

₹29.14

Beta

0.76

Return on equity

1.24%

Earnings per share (TTM)

₹0.31

Dividend yield

Net profit/quarter (Cr)

-₹0.26

Lotus Eye Hosp & Inst L financials

(Values in Cr)

Revenue

Net income

Particulars	Dec 25 (₹ value in crores)
Revenue	₹13.55
Operating expense	₹14.17
Net income	-₹0.26
Net profit margin	-1.91%
Earning per share	-₹0.13
EBITDA	₹0.88
Effective tax rate	28.94%

Particulars	Sep 25 (₹ value in crores)
Revenue	₹13.04
Operating expense	₹13.22
Net income	₹0.12
Net profit margin	0.92%
Earning per share	₹0.06
EBITDA	₹1.04
Effective tax rate	-57.14%

Particulars	Jun 25 (₹ value in crores)
Revenue	₹13.52
Operating expense	₹12.97
Net income	₹0.54
Net profit margin	3.99%
Earning per share	₹0.26
EBITDA	₹1.67
Effective tax rate	26.02%

Particulars	Mar 25 (₹ value in crores)
Revenue	₹11.51
Operating expense	₹11.19
Net income	₹0.25
Net profit margin	2.17%
Earning per share	₹0.12
EBITDA	₹0.35
Effective tax rate	70.23%

Particulars	Dec 24 (₹ value in crores)
Revenue	₹12.25
Operating expense	₹12.89
Net income	-₹0.24
Net profit margin	-1.95%
Earning per share	-₹0.11
EBITDA	₹1.01
Effective tax rate	44.18%

Particulars	Mar 25 (₹ value in crores)
Revenue	₹49.56
Operating expense	₹49.50
Net income	₹0.74
Net profit margin	1.49%
Earning per share	₹0.36
EBITDA	₹4.75
Effective tax rate	46.37%

Particulars	Mar 24 (₹ value in crores)
Revenue	₹48.21
Operating expense	₹45.51
Net income	₹2.91
Net profit margin	6.03%
Earning per share	₹1.40
EBITDA	₹7.84
Effective tax rate	27.43%

Particulars	Mar 23 (₹ value in crores)
Revenue	₹47.04
Operating expense	₹42.54
Net income	₹4.08
Net profit margin	8.67%
Earning per share	₹1.96
EBITDA	₹8.73
Effective tax rate	27.78%

Particulars	Mar 22 (₹ value in crores)
Revenue	₹38.91
Operating expense	₹35.69
Net income	₹2.98
Net profit margin	7.65%
Earning per share	₹1.44
EBITDA	₹6.72
Effective tax rate	27.13%

Particulars	Mar 21 (₹ value in crores)
Revenue	₹32.37
Operating expense	₹31.20
Net income	₹1.57
Net profit margin	4.85%
Earning per share	₹0.75
EBITDA	₹4.38
Effective tax rate	21.1%

Particulars (annual)	Mar 25 (₹ value in crores)
Book value per share	₹28.85
Return on Equity (ROE)	1.24%
Return on Capital Employed (ROCE)	2.99%
Total debt to equity ratio	0.04
EBITDA margin	9.83%

Particulars (annual)	Mar 24 (₹ value in crores)
Book value per share	₹28.57
Return on Equity (ROE)	4.97%
Return on Capital Employed (ROCE)	7.06%
Total debt to equity ratio	0.02
EBITDA margin	16.47%

Particulars (annual)	Mar 23 (₹ value in crores)
Book value per share	₹27.69
Return on Equity (ROE)	7.27%
Return on Capital Employed (ROCE)	10.18%
Total debt to equity ratio	0.02
EBITDA margin	18.77%

Particulars (annual)	Mar 22 (₹ value in crores)
Book value per share	₹26.26
Return on Equity (ROE)	5.55%
Return on Capital Employed (ROCE)	7.81%
Total debt to equity ratio	0.02
EBITDA margin	17.48%

Particulars (annual)	Mar 21 (₹ value in crores)
Book value per share	₹25.34
Return on Equity (ROE)	3.02%
Return on Capital Employed (ROCE)	4.01%
Total debt to equity ratio	0.01
EBITDA margin	13.78%

Particulars	Mar 25 (₹ value in crores)
Cash and short term investments	₹4.15
Total assets	₹69.57
Total liabilities	₹69.57
Total equity	₹60.00
Shares outstanding	₹2.07
Price to book ratio	₹2.42
Return on assets (%)	1.06%
Return on capital	1.23%

Particulars	Mar 24 (₹ value in crores)
Cash and short term investments	₹7.04
Total assets	₹66.62
Total liabilities	₹66.62
Total equity	₹59.40
Shares outstanding	₹2.07
Price to book ratio	₹1.98
Return on assets (%)	4.37%
Return on capital	4.91%

Particulars	Mar 23 (₹ value in crores)
Cash and short term investments	₹8.41
Total assets	₹63.18
Total liabilities	₹63.18
Total equity	₹57.57
Shares outstanding	₹2.07
Price to book ratio	₹2.10
Return on assets (%)	6.45%
Return on capital	7.08%

Particulars	Mar 22 (₹ value in crores)
Cash and short term investments	₹8.84
Total assets	₹61.60
Total liabilities	₹61.60
Total equity	₹54.60
Shares outstanding	₹2.07
Price to book ratio	₹2.03
Return on assets (%)	4.84%
Return on capital	5.47%

Particulars	Mar 21 (₹ value in crores)
Cash and short term investments	₹9.91
Total assets	₹59.22
Total liabilities	₹59.22
Total equity	₹52.69
Shares outstanding	₹2.07
Price to book ratio	₹1.65
Return on assets (%)	2.64%
Return on capital	2.98%

Particulars	Mar 25 (₹ value in crores)
Net income	₹1.37
Cash from operations	₹3.32
Cash from investing	-₹3.99
Cash from financing	-₹1.59
Net change in cash	-₹2.88
Free cash flow	₹8.15

Particulars	Mar 24 (₹ value in crores)
Net income	₹4.00
Cash from operations	₹6.94
Cash from investing	-₹3.68
Cash from financing	-₹3.37
Net change in cash	-₹1.37
Free cash flow	₹12.50

Particulars	Mar 23 (₹ value in crores)
Net income	₹5.65
Cash from operations	₹5.79
Cash from investing	-₹2.19
Cash from financing	-₹1.70
Net change in cash	₹0.48
Free cash flow	₹8.89

Particulars	Mar 22 (₹ value in crores)
Net income	₹4.10
Cash from operations	₹5.25
Cash from investing	-₹3.93
Cash from financing	-₹1.57
Net change in cash	-₹1.09
Free cash flow	₹9.94

Particulars	Mar 21 (₹ value in crores)
Net income	₹1.91
Cash from operations	₹3.02
Cash from investing	₹0.48
Cash from financing	-₹0.31
Net change in cash	₹2.89
Free cash flow	₹3.50

Company name	Price	P/E	P/B	Market cap	52 week low/high
APOLLO HOSPITALS ENTER. L	₹8,081.60	63.97	12.78	₹1,16,201.01	₹6,680.00 / ₹8,249.95
FORTIS MALAR HOSPITALS LIMITED	₹54.06	22.34	2.94	₹101.32	₹40.75 / ₹81.00
SHREE PACETRONIX LTD.	₹136.00	20.51	3	₹51.00	₹66.10 / ₹283.15
TRANSGENE BIOTEK LTD.	₹3.20	0	2.63	₹24.25	₹1.83 / ₹5.26
VIMTA LABS LIMITED	₹478.55	35.16	6.23	₹2,137.65	₹377.30 / ₹902.85

Company name	Price	P/E	P/B	Market cap	52 week low/high
APOLLO HOSPITALS ENTER. L	₹8,081.60	63.97	12.78	₹1,16,201.01	₹6,680.00 / ₹8,249.95
FORTIS MALAR HOSPITALS LIMITED	₹54.06	22.34	2.94	₹101.32	₹40.75 / ₹81.00
SHREE PACETRONIX LTD.	₹136.00	20.51	3	₹51.00	₹66.10 / ₹283.15
TRANSGENE BIOTEK LTD.	₹3.20	0	2.63	₹24.25	₹1.83 / ₹5.26
VIMTA LABS LIMITED	₹478.55	35.16	6.23	₹2,137.65	₹377.30 / ₹902.85

Lotus Eye Hosp & Inst L technical summary

₹104

-2.4 ▼

Bearish

Bullish

5 Day110.5

10 Day112.7

12 Day113.1

20 Day113.5

26 Day113.3

50 Day113

100 Day112.6

200 Day107.5

Investment Returns

Over 1 Month1.87%▼

Over 3 Months10.25%▼

Over 6 Months0.27%▲

Over 1 Year39.82%▲

Lotus Eye Hosp & Inst L Shareholding pattern

Public

59.84%

Promoter holdings

40.13%

FII

DII

0.01%

Promoter shares

87.15%

Promoter shares	Share	Category
Sangeetha S	72,74,272 (34.98%)	Shareholding of Promoter and Promoter Group
Kovai Purani Finance Private Limited	15,93,234 (7.66%)	Public Shareholding
Vramath Investment Consultancy Pvt Ltd	10,06,744 (4.84%)	Public Shareholding
Vramath Financial Services Pvt Ltd	9,71,873 (4.67%)	Public Shareholding
Rajiv Choudhary	9,42,005 (4.53%)	Public Shareholding

About LOTUS EYE HOSP & INST L

Lotus Eye Hospital & Institute Limited, a trust hospital, was originally incorporated as 'Kalaivani Health Centre Pvt. Limited' on 14 March, 1997. The name of the Company was changed to 'Lotus Eye Care Hospital Pvt. Limited' on 23 January, 2006 and later on, the Company was converted into a Public Limited Company on October 16, 2007 and subsequently, the name was changed to Lotus Eye Hospital & Institute Limited on April 12, 2013. Founded in 1990 by renowned ophthalmic surgeon late Dr. S.K. Sundaramoorthy, the Company operates 9 Eye Care centers in Tamil Nadu and Kerala: 7 Centres in Tamil Nadu: Coimbatore (Peelamedu, RS puramand Saravanampatti), Salem , Tirupur Mettupalayam and Karur. 2 Centresin Kerala: Kochi and Mulanthuruthy. Lotus Eye Care Hospital is the state of art eye care hospital group functioning in South India with specialization in super-specialty service related to eye care. The Company is engaged in the field of Ophthalmology (Eye) and its related operation. Lotus has two centers in Coimbatore, one in down town and another in civil aerodrome inaugurated in the year 2002. The Salem Center is located in the heart of the city and it was started in the year 2004. The Tirupur Center started in 2007 is also functioning in prime location in the city. These hospitals have hi-tech eye care equipments and ophthalmic experts backed by well-trained paramedical and administrative team. All the centers have fully computerized modern setup manned by medical and administrative staff. The network of eye care hospitals has 9 operation theatres and 3 Lasik laser equipments. Most of the eye operations are performed as a day care procedure and therefore the company has maintained optimum number of beds. The hospitals total bed strength of all the centers is 120 beds excluding eye camp beds. In the year 1998, Lotus introduced Multi Scan Lasik and in the year 2002 Wave front based Esiris Custom Lasik for the first time in India. Lotus was the first Eye hospital in South East Asia to have Epilasik in July 2004. In the year June 2005 Lotus introduced the most advanced technology of Zyoptix and combined two superior technologies Epilasik and Zyoptix known as Zyoptix Integrated Epilasik to achieve supervision. In the year 2006-2007, Dr. S.K.S.Eye Care Centre Pvt. Ltd., (Dr S K Sundaramoorthy promoter of the company) was merged with company w.e.f. 01 December, 2006. The Company opened a new Center in Tirupur in June, 2007. The Company raised Rs 38 Crores by issue of 1,00,00,000 equity shares of Rs. 10 each at premium of Rs. 28 per share to finance the part of expansion project on 27 June, 2008 and the shares got listed both Bombay Stock Exchange and National Stock Exchange on 11th July, 2008. It launched Intralasa Lasik/ Zyoptix Laser Technology in 2009; opened a new center in Mettupalayam in 2010; opened new center in Kochi, Kerala; introduced Zyoptix Supracor in Tamilnadu; launched Zyoptix Ultimate 217P technology in 2011. In 2013, it launched LenSx for Laser Cataract and Laser Corneal Surgery; in 2014, opened Mulanthuruthy Centre in Kerala; launched Kerala's 1st ReLEx SMILE at Kochi in 2016; launched Schwind Amaris 750Hz Touch Free Lasik Technology at RS Puram in 2019 and opened a new center at Saravanampatti, Coimbatore in 2023. The Company expanded its operations by opening another center at Karur on 12 July 2024 as the 9th Center commencing its business.

Parent Organisation

Indian Private

NSE Symbol

LOTUSEYE

Founded

1997

LOTUS EYE HOSP & INST L CORPORATE ACTION

Dividend date	Dividend amount	Dividend type	Record date	Instrument type
18 Sept 2023	0.5	Final	18 Sept 2023	Equity shares
08 Sept 2022	0.5	Final	10 Sept 2022	Equity shares
08 Sept 2021	0.5	Final	11 Sept 2021	Equity shares
14 Sept 2018	0.5	Final	18 Sept 2018	Equity shares
02 Aug 2017	0.5	Final	04 Aug 2017	Equity shares

View more stocks

apollo hospitals enter. l

₹8,037.5

▼ 0.55%

max healthcare institute limit

₹1,056.4

▲ 0.59%

fortis healthcare ltd

₹959.65

▼ 0.41%

aster dm healthcare limited

₹756.65

▲ 0.39%

narayana hrudayalaya limited

₹1,851.9

▲ 0.58%

global health limited

₹1,236.3

▼ 0.49%

krishna institute of medical s

₹719.75

▼ 5.50%

What’s trending

All stocks

HBLEAS

HB LEASING & FINANCE CO.LTD.

9.6

+1.6 (+20%)

FCL

FINEOTEX CHEMICAL LTD.

30.55

+5.09 (+19.99%)

OPTIFIN

OPTIMUS FINANCE LIMITED

14.24

+2.37 (+19.97%)

FCL

FINEOTEX CHEMICAL LIMITED

30.52

+5.08 (+19.97%)

View all

Top gainers

TECHM

TECH MAHINDRA LIMITED

INFOSYS LIMITED

BHARTI AIRTEL LIMITED

1938.1

+32.70 (+1.72%)

SUNPHARMA

SUN PHARMACEUTICAL IND L

1905.8

+27.60 (+1.47%)

View all

Top losers

TATA STEEL LIMITED

POWER GRID CORP. LTD.

STATE BANK OF INDIA

NTPC LTD

Frequently asked questions

 As of 18/05/2026, at 14:19 PM, the Lotus Eye Hosp & Inst L share price stands at ₹104.88.

Related tags

Disclaimer

*Disclaimer for Bajaj Finance Limited (‘BFL’):

Stock trading business is carried by Bajaj Financial Securities Limited ("BFSL"), a broker and Depository Participant registered with Securities Exchange Board of India and offers various products/services related to Securities market (Securities market products/services). BFL merely facilitates display of data shared by BFSL on its webpage/mobile application. Such data received from BFSL, or any of its service providers is on “as is” basis. BFL does not make any representation or warranty, express or implied, regarding accuracy, completeness of such data displayed herein.

When you opt to avail the Securities market products/services of BFSL by clicking on the BFSL weblink/mobile app, you will be redirected to BFSL's web page/mobile app for initiation and completion of the transaction. You are supposed to exercise independent diligence by reading all the related documents carefully before deciding to invest in Securities market Products/services.

BFL is a Non-Banking Financial Company carrying the business of acceptance of deposits and providing lending solutions to Retail and Corporate customers. BFL does not offer nor advice on Securities market products/services and shall not be liable or responsible for any of your investment decision."

**Disclaimer: For Bajaj Financial Securities Limited

Investments in the securities market are subject to market risk, read all related documents carefully before investing.

Broking services offered by Bajaj Financial Securities Limited (Bajaj Broking). Reg Office: Bajaj Auto Limited Complex, Mumbai –Pune Road Akurdi Pune 411035. Corporate Office: Bajaj Financial Securities Limited, 1st Floor, Mantri IT Park, Tower B, Unit No 9 & 10, Viman Nagar, Pune, Maharashtra 411014. SEBI Registration No.: INZ000218931 | BSE Cash/F&O/CDS (Member ID:6706) | NSE Cash/F&O/CDS (Member ID: 90177) | DP registration No: IN-DP-418-2019 | CDSL DP No.: 12088600 | NSDL DP No. IN304300 | AMFI Registration No.: ARN –163403.

Details of Compliance Officer: Mr. Boudhayan Ghosh (For Broking/DP/Research) | Email: compliance_sec@bajajbroking.in | Contact No.: 020-4857 4486. For any investor grievances write to compliance_sec@bajajbroking.in/ compliance_dp@bajajbroking.in (DP related)

This content is for educational purpose only. Securities quoted are exemplary and not recommendatory.

Research Services are offered by Bajaj Broking as Research Analyst under SEBI Regn: INH000010043.

For more disclaimer, check here: https://www.bajajbroking.in/disclaimer

LOTUS EYE HOSP & INST L

Lotus eye hosp & inst l share price update

Lotus Eye Hosp & Inst L stock performance

₹101.02

₹106.56

₹67.72

₹147

Lotus Eye Hosp & Inst L fundamentals

Lotus Eye Hosp & Inst L financials

Particulars

Dec 25 (₹ value in crores)

Revenue

₹13.55

Operating expense

₹14.17

Net income

-₹0.26

Net profit margin

-1.91%

Earning per share

-₹0.13

EBITDA

₹0.88

Effective tax rate

28.94%

Particulars

Sep 25 (₹ value in crores)

Revenue

₹13.04

Operating expense

₹13.22

Net income

₹0.12

Net profit margin

0.92%

Earning per share

₹0.06

EBITDA

₹1.04

Effective tax rate

-57.14%

Particulars

Jun 25 (₹ value in crores)

Revenue

₹13.52

Operating expense

₹12.97

Net income

₹0.54

Net profit margin

3.99%

Earning per share

₹0.26

EBITDA

₹1.67

Effective tax rate

26.02%

Particulars

Mar 25 (₹ value in crores)

Revenue

₹11.51

Operating expense

₹11.19

Net income

₹0.25

Net profit margin

2.17%

Earning per share

₹0.12

EBITDA

₹0.35

Effective tax rate

70.23%

Particulars

Dec 24 (₹ value in crores)

Revenue

₹12.25

Operating expense

₹12.89

Net income